These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 32696514)
1. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors. Shaaban MA; Kamal AM; Faggal SI; Farag NA; Aborehab NM; Elsahar AE; Mohamed KO Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Shabaan MA; Kamal AM; Faggal SI; Elsahar AE; Mohamed KO Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900308. PubMed ID: 32031284 [TBL] [Abstract][Full Text] [Related]
3. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study. El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. Lamie PF; Philoppes JN; Rárová L Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity. Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994 [TBL] [Abstract][Full Text] [Related]
7. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Gedawy EM; Kassab AE; El Kerdawy AM Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX. Omar YM; Abdu-Allah HHM; Abdel-Moty SG Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191 [TBL] [Abstract][Full Text] [Related]
10. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related]
11. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289 [TBL] [Abstract][Full Text] [Related]
12. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583 [TBL] [Abstract][Full Text] [Related]